Article Text

PDF
Maintenance treatment with olanzapine reduces relapse in people with bipolar I disorder who have responded to acute olanzapine treatment

Statistics from Altmetric.com


 
 Q Does olanzapine prevent relapse of bipolar I disorder in people who have responded to acute treatment with olanzapine for a manic or mixed episode?

METHODS

Embedded ImageDesign:

Multicentre randomised controlled trial.

Embedded ImageAllocation:

Not clear.

Embedded ImageBlinding:

Double blind.

Embedded ImageFollow up period:

48 weeks.

Embedded ImageSetting:

44 sites in the USA and 5 sites in Romania; time period not stated.

Embedded ImagePatients:

361 people, aged 18 or over, who achieved symptomatic remission from a DSM-IV bipolar I manic or mixed episode (Young Mania Rating scale (YMRS) score ⩽12 and 21 item Hamilton Depression Rating Scale (HAM-D) score ⩽8 for 2 consecutive weeks) following 6–12 weeks of acute treatment with olanzapine.

Embedded ImageIntervention:

Olanzapine (5–20 mg/day) or placebo.

Embedded ImageOutcomes:

Symptomatic relapse into any mood episode (YMRS or HAM-D score ⩾15, or hospitalisation for a manic, depressive, or mixed episode); time to symptomatic …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.